SIC
IBB icon

Shoker Investment Counsel’s iShares Biotechnology ETF IBB Stock Holding History

Shoker Investment Counsel’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-5,128
Closed -$559K – 99
2019
Q2 		$559K Sell
5,128
-1,761
-26% -$187K 0.41% 57
2019
Q1 		$770K Sell
6,889
-843
-11% -$92.5K 0.57% 50
2018
Q4 		$745K Sell
7,732
-517
-6% -$54.9K 0.62% 46
2018
Q3 		$1M Buy
8,249
+176
+2% +$20.7K 0.73% 43
2018
Q2 		$886K Sell
8,073
-112
-1% -$12K 0.66% 45
2018
Q1 		$873K Sell
8,185
-296
-3% -$32.8K 0.66% 43
2017
Q4 		$905K Buy
8,481
+57
+0.7% +$6.09K 0.65% 46
2017
Q3 		$936K Sell
8,424
-2,184
-21% -$233K 0.71% 38
2017
Q2 		$1.1M Buy
10,608
+576
+6% +$56.7K 0.86% 37
2017
Q1 		$980K Sell
10,032
-1,179
-11% -$113K 0.82% 37
2016
Q4 		$991K Buy
+11,211
New +$1.02M 0.82% 39

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
N
Natixis Paris, France $28B AUM 26.79% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Shoker Investment Counsel's IBB Position: Q3 2019 in Review

Shoker Investment Counsel sold out of iShares Biotechnology ETF (IBB) in Q3 2019, closing a stake of 5,128 shares — an estimated $559K sold.

Shoker Investment Counsel first reported a position in IBB in Q4 2016 and held it in 11 quarters. The position peaked at $1.1M in Q2 2017. 597 funds tracked by Wall St. Rank hold IBB as of Q3 2019.

  • Shoker Investment Counsel reported no remaining iShares Biotechnology ETF position as of Q3 2019 after selling out during the quarter.
  • Shoker Investment Counsel sold 5,128 iShares Biotechnology ETF shares in Q3 2019, an estimated $559K.
  • Shoker Investment Counsel first reported a position in iShares Biotechnology ETF in Q4 2016 and held it in 11 quarters.
  • Shoker Investment Counsel's iShares Biotechnology ETF position peaked at $1.1M in Q2 2017.
  • 597 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2019.

Based on Shoker Investment Counsel's 13F filing for Q3 2019, filed 6 Nov 2019.